Medicis Declares Cash Dividend
September 21, 2012 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company's Board of Directors declared a quarter-end cash dividend of $0.10 per issued and outstanding...
Valeant Pharmaceuticals International, Inc. Agrees to Acquire Medicis Pharmaceutical Corporation for $44.00 Per Share in Cash
September 03, 2012 14:00 ET
|
Medicis Pharmaceutical Corporation
Combination Creates a Global Leader in Dermatology
Transaction Values Medicis at Approximately $2.6 Billion
At Least $225 Million Run Rate in Annual Cost Synergies Expected to be Achieved...
Medicis Reports Second Quarter 2012 Financial Results
August 08, 2012 16:05 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Aug. 8, 2012 (GLOBE NEWSWIRE) --
Second Quarter 2012 Highlights
Revenues of approximately $197 million (vs Guidance of $185-$195 million)
Non-GAAP Cash EPS of $0.52...
Medicis Announces 2012 Second Quarter Conference Call and Webcast
August 06, 2012 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Aug. 6, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company expects to report 2012 second quarter financial results after the market closes on Wednesday,...
Medicis Declares Cash Dividend
June 14, 2012 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., June 14, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company's Board of Directors declared a quarter-end cash dividend of $0.10 per issued and...
Medicis to Present at Jefferies Global Healthcare Conference
June 05, 2012 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., June 5, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Jefferies 2012 Global Healthcare Conference in New York. A live...
Medicis to Present at Goldman Sachs Global Healthcare Conference
June 04, 2012 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., June 4, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Goldman Sachs 33rd Annual Global Healthcare Conference in Rancho...
Medicis to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 14, 2012 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., May 14, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Bank of America Merrill Lynch 2012 Health Care Conference in Las...
Medicis Announces Pricing of $450 Million of Convertible Notes
May 11, 2012 07:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., May 11, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) (the "Company") today announced the pricing of its public offering of $450 million aggregate principal amount of convertible...
Medicis Announces Offering of $400 Million of Convertible Notes
May 10, 2012 07:20 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., May 10, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) (the "Company") today announced that it intends, subject to market and other conditions, to offer $400 million aggregate...